News

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...
Joie Armstrong knows that a home-cooked meal featuring whole foods is the best way to get her daily nutrients. She takes cues ...
Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...
Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...
Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.
HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...
A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...
Brown-Forman: GLP-1s, cannabis and Gen Z continue to weigh on demand. Tesla gains as White House aides hint at possible thaw ...
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight ...